When did PALISADE BIO INC (PALI) report earnings last quarter?
PALISADE BIO INC (PALI) last reported earnings on 3/20/2026.
NASDAQ:PALI • US6963894026
Past quarterly earnings results for PALISADE BIO INC (PALI), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.08 | -0.08 | 3.52% | 94.83% | - | - | ||
| Q3 2025 | -0.38 | -0.28 | -35.80% | 83.62% | - | - | ||
| Q2 2025 | -0.58 | -0.57 | -1.42% | 82.53% | - | - | ||
| Q1 2025 | -0.47 | -0.71 | 34.17% | 89.76% | - | - | ||
| Q4 2024 | -1.55 | -2.03 | 23.66% | 76.02% | - | - | ||
| Q3 2024 | -2.32 | -3.42 | 32.15% | 64.85% | - | - | ||
| Q2 2024 | -3.32 | -2.99 | -11.13% | 58.24% | - | - | ||
| Q1 2024 | -4.59 | -4.90 | 6.25% | 43.33% | - | -100.00% | ||
| Q4 2023 | -6.45 | -5.28 | -22.19% | -106.65% | - | - | ||
| Q3 2023 | -6.60 | -6.03 | -9.49% | 89.00% | - | - | ||
| Q2 2023 | -7.95 | -6.93 | -14.70% | 91.17% | - | - | ||
| Q1 2023 | -8.10 | -11.06 | 26.78% | 95.85% | 250K | - | - | |
| Q4 2022 | 97.05 | -37.26 | 360.50% | 61.75% | - | - | ||
| Q3 2022 | -60.00 | -61.20 | 1.96% | -119.05% | - | - | ||
| Q2 2022 | -90.00 | -175.95 | 48.85% | -11,900.00% | - | - | ||
| Q1 2022 | -195.00 | -214.20 | 8.96% | - | - | - | ||
| Q4 2021 | 60.00 | -179.78 | 133.38% | - | - | -100.00% | ||
| Q3 2021 | 315.00 | -275.40 | 214.38% | - | - | -100.00% | ||
| Q2 2021 | -0.75 | - | - | - | -100.00% | |||
| Q1 2021 | - | - | - | -100.00% | ||||
| Q4 2020 | - | - | 2.5K | - | - | |||
| Q3 2020 | - | - | 2.5K | - | - | |||
| Q2 2020 | - | - | 2.5K | - | - | |||
| Q1 2020 | - | - | 6K | - | - |
Notes
PALISADE BIO INC (PALI) last reported earnings on 3/20/2026.
PALISADE BIO INC (PALI) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, PALISADE BIO INC (PALI) has beaten EPS estimates in 3 out of 4 releases.